
    
      At the time of the inception of this study, there were no published randomized controlled
      trial on the efficacy of the Biopatch in reducing bloodstream infections. Preliminary data
      has shown that the Biopatch decreases colonization of the catheter exit site and thereby
      decrease bloodstream infections but this was at that time only theoretical.
    
  